CVE-2017-18223 : Security Advisory and Response
Learn about CVE-2017-18223, a vulnerability in BMC Remedy AR System allowing attackers to gain administrative access. Find out affected versions and mitigation steps.
Administrative access can be obtained by attackers on BMC Remedy AR System versions prior to 9.1 SP3, when Remedy AR Authentication is enabled.
Understanding CVE-2017-18223
BMC Remedy AR System before 9.1 SP3, when Remedy AR Authentication is enabled, allows attackers to obtain administrative access.
What is CVE-2017-18223?
This CVE refers to a vulnerability in BMC Remedy AR System that enables attackers to gain administrative access on versions preceding 9.1 SP3 when Remedy AR Authentication is turned on.
The Impact of CVE-2017-18223
The vulnerability allows unauthorized individuals to gain administrative privileges on the affected systems, potentially leading to unauthorized access and control over sensitive data.
Technical Details of CVE-2017-18223
Vulnerability Description
Administrative access can be obtained by attackers on BMC Remedy AR System versions prior to 9.1 SP3, when Remedy AR Authentication is enabled.
Affected Systems and Versions
- Product: BMC Remedy AR System
- Versions Affected: Prior to 9.1 SP3
Exploitation Mechanism
Attackers can exploit this vulnerability when Remedy AR Authentication is enabled, allowing them to gain administrative access.
Mitigation and Prevention
Immediate Steps to Take
- Disable Remedy AR Authentication if not required
- Implement strong access controls and authentication mechanisms
- Monitor system logs for any suspicious activities
Long-Term Security Practices
- Regularly update BMC Remedy AR System to the latest version
- Conduct security assessments and penetration testing to identify and address vulnerabilities
Patching and Updates
Ensure that BMC Remedy AR System is updated to version 9.1 SP3 or later to mitigate the vulnerability.